Document is current
Any future updates will be listed below
-
Authors
Raffaele, Marco
Kovacovicova, Kristina
Biagini, Tommaso
Lo Re, Oriana
Frohlich, Jan
Giallongo, Sebastiano
Nhan, James D.
Giannone, Antonino Giulio
Cabibi, Daniela
Ivanov, Martin
Tonchev, Anton B.
Mistrik, Martin
Lacey, Matthew
Dzubak, Petr
Gurska, Sona
Hajduch, Marian
Bartek, Jiri
Mazza, Tommaso
Micale, Vincenzo
Curran, Sean P.
Vinciguerra, Manlio https://orcid.org/0000-0002-1768-3894
-
Funding
Funding for this research was provided by:
European Regional Development Fund (CZ.02.1.01/0.0/0.0/15_003/0000492, CZ.02.1.01/0.0/0.0/16_019/0000868)
Horizon 2020 Framework Programme (856871)
Ministerstvo Zdravotnictví Ceské Republiky (NV18-03-00058)
National Institute on Aging (P30AG068345, R01AG058610)
Czech Ministry of Education, Youth and Sports (CZ-OPENSCREEN– LM2018130, EATRIS-CZ – LM2018133)
- License Information
-
More Information
Article History
Received: 11 October 2021
Accepted: 5 November 2021
First Online: 24 November 2021
Declarations
:
: MM, JB, and MH are co-inventors on a patent application: EP 3 552 605 A1, utilizing MCOPPB as a medicament with senolytic effects. Other authors declare no other competing interests.
